LISA WOOTEN: Open Payments
NPI 1033469366 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 117 payments from 20 companies in 2025. Trend: 2023 $1,742 · 2024 $2,152 · 2025 $2,262
Food & beverage: $2,242Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $650 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 31 | $430 |
| Phathom Pharmaceuticals, Inc. | 17 | $199 |
| Janssen Biotech, Inc. | 10 | $194 |
| Madrigal Pharmaceuticals | 4 | $191 |
| Ipsen Biopharmaceuticals, Inc | 5 | $99 |
| Janssen Scientific Affairs, LLC | 1 | $92 |
| GENZYME CORPORATION | 4 | $85 |
| QOL Medical, LLC | 3 | $84 |
| Ardelyx, Inc. | 3 | $60 |
Products named: XIFAXAN, TREMFYA, VOQUEZNA, REZDIFFRA, RINVOQ, SKYRIZI, CREON, DUPIXENT.
Industry payments across KY — which companies pay providers there.
